Enterprise Value
342.4M
Cash
31.02M
Avg Qtr Burn
-1.429M
Short % of Float
5.16%
Insider Ownership
5.05%
Institutional Own.
77.24%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Avance® Nerve Graft Details Nerve discontinuities | BLA Submission |